Kaye Edward M. MD - Insider Transactions
Insider Type
individual
Companies
2
Average
985,933
Total Txns
17
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2024 | 0 | 5 | -5 | 0.00 | 888,524.00 | -888,524.00 |
| 2025 | 0 | 12 | -12 | 0.00 | 4,041,142.67 | -4,041,142.67 |
| Total: | 0 | 17 | 10 | 0.00 | 4,929,666.67 | -4,929,666.67 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Cytokinetics, Incorporated Common Stock US23282W6057 |
60.00 USD |
6,757 Sold |
405,420 USD |
06/10/2025 | 06/10/2025 |
| Stoke Therapeutics, Inc. Common Stock US86150R1077 |
25.09 USD |
42,461 Sold |
1,065,206 USD |
03/10/2025 | 03/10/2025 |
| Cytokinetics, Incorporated Common Stock US23282W6057 |
55.08 USD |
6,695 Sold |
368,761 USD |
30/09/2025 | 30/09/2025 |
| Cytokinetics, Incorporated Common Stock US23282W6057 |
50.00 USD |
6,756 Sold |
337,800 USD |
02/09/2025 | 02/09/2025 |
| Stoke Therapeutics, Inc. Common Stock US86150R1077 |
20.14 USD |
14,860 Sold |
299,260 USD |
29/08/2025 | 02/09/2025 |
| Stoke Therapeutics, Inc. Common Stock US86150R1077 |
20.00 USD |
1,029 Sold |
20,580 USD |
29/08/2025 | 29/08/2025 |
| Stoke Therapeutics, Inc. Common Stock US86150R1077 |
20.13 USD |
45,996 Sold |
925,858 USD |
29/08/2025 | 03/09/2025 |
| Stoke Therapeutics, Inc. Common Stock US86150R1077 |
18.24 USD |
12,126 Sold |
221,154 USD |
18/08/2025 | 18/08/2025 |
| Cytokinetics, Incorporated Common Stock US23282W6057 |
32.10 USD |
3,636 Sold |
116,716 USD |
05/06/2025 | 05/06/2025 |
| Cytokinetics, Incorporated Common Stock US23282W6057 |
32.10 USD |
3,636 Sold |
116,716 USD |
05/06/2025 | 05/06/2025 |